Impact News +++ XFRA: INSTRUMENT_SUSPENSION - CA60283L8087 (XETRA) +++ MINERA ALAMOS Aktie +3,17%

QUIDELORTHO Aktie

>QUIDELORTHO Aktienkurs

16.355 EUR +2.5% (TradegateBSX)

Ask: 16.34 EUR / 307 Stück

Bid: 16.105 EUR / 311 Stück

Tagesumsatz: 4 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

QUIDELORTHO Aktie über LYNX handeln

Intraday

1 Jahr

>QUIDELORTHO Performance

1 Woche: +43,5%

1 Monat: +42,9%

3 Monate: +24,2%

6 Monate: -35,1%

1 Jahr: -35,4%

laufendes Jahr: -36,2%

>QUIDELORTHO Aktie

Name:

QUIDELORTHO DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US2197981051 / A3DNGX

Symbol/ Ticker:

QL1A (Frankfurt) / QDEL (NASDAQ)

Kürzel:

FRA:QL1A, ETR:QL1A, QL1A:GR, NASDAQ:QDEL

Index:

Webseite:

https://www.quidelortho.c..

Profil:

QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagnostic products designed to detect and diagnose a va..
>Volltext..

Marktkapitalisierung:

826.03 Mio. EUR

Unternehmenswert:

3189.85 Mio. EUR

Umsatz:

2335.38 Mio. EUR

EBITDA:

377.9 Mio. EUR

Nettogewinn:

-1063.69 Mio. EUR

Gewinn je Aktie:

-15.65 EUR

Schulden:

2525.21 Mio. EUR

Liquide Mittel:

123.33 Mio. EUR

Operativer Cashflow:

5.8 Mio. EUR

Bargeldquote:

0.15

Umsatzwachstum:

-9.98%

Gewinnwachstum:

-239.78%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

QUIDELORTHO

Letzte Datenerhebung:

30.06.26

>QUIDELORTHO Kennzahlen

Aktien/ Unternehmen:

Aktien: 68.19 Mio. St.

Frei handelbar: 98.82%

Leerverk. Aktien: 18.12%

Rückkaufquote: -0.52%

Mitarbeiter: 6500

Umsatz/Mitarb.: 0.37 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 33.95%

Bewertung:

KGV: -

KGV lG: 7.31

KUV: 0.31

KBV: 0.5

PEG-Ratio: -

EV/EBITDA: 8.44

Rentabilität:

Bruttomarge: 38%

Gewinnmarge: -45.55%

Operative Marge: -0.66%

Managementeffizenz:

Gesamtkaprendite: -20.03%

Eigenkaprendite: -49.95%

>QUIDELORTHO Peer Group

Gesundheit, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Magen-Darm-Erkrankungen & -behandlung, Herz-Kreislauf- Behandlung/ Kardiologie

>QUIDELORTHO Chart & Kurs - NASDAQ

>QUIDELORTHO News

30.06.26 - 05:00	Top Biotech Gainers: UPC Expands Patent Portfolio, All Eyes On SLS, What′s Behind The QDEL Rumor? (RTTNews)
	Today's top gainers include Universe Pharma, which expanded its pharmaceutical patent portfolio; Decoy Therapeutics, following the announcement of a PIPE financing; QuidelOrtho, on reports that it is exploring the sale of one of its business units; and SELLAS, which is approaching a key data readout, among others....

29.06.26 - 15:54	Starke Quartalszahlen und Hantavirus-Fantasie beflügeln QuidelOrtho-Aktie (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.06.26 - 14:30	QuidelOrtho plans to sell testing unit for $1.5B: FT (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.06.26 - 13:27	QuidelOrtho taps former Masimo executive Micah Young as CFO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.06.26 - 13:15	QuidelOrtho Appoints Micah Young as Chief Financial Officer (PR Newswire)
	Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho" or the "Company"), a leading global provider of diagnostic solutions, today......

17.06.26 - 19:00	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
	QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk....

12.06.26 - 16:00	Is the Options Market Predicting a Spike in QuidelOrtho Stock? (Zacks)
	Investors need to pay close attention to QDEL stock based on the movements in the options market lately....

04.06.26 - 19:00	QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue? (Zacks)
	QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

03.06.26 - 21:15	QuidelOrtho′s Respiratory Exposure Remains a Key Near-Term Risk (Zacks)
	QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share....

02.06.26 - 13:15	QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies (PR Newswire)
	SAN DIEGO, June 2, 2026 /PRNewswire/ -- QuidelOrtho, a global leader in diagnostic innovation, and the Allo Hope Foundation, a nonprofit dedicated to supporting families and clinicians managing maternal alloimmunization, announced a new collaboration focused on improving prenatal care......

21.05.26 - 15:21	When Blood Compatibility Becomes a Pregnancy Risk (PR Newswire)
	SAN DIEGO, May 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 58 of its Science Bytes podcast, focusing on hemolytic disease of the fetus and newborn (HDFN) – a serious but often underrecognized condition......

20.05.26 - 13:01	QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences (PR Newswire)
	SAN DIEGO, May 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, announced today that members of its management team will participate in two upcoming investor conferences: William Blair......

06.05.26 - 19:45	QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
	QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins and cash flow....

06.05.26 - 11:36	QuidelOrtho forecasts $2.7B-$2.75B 2026 revenue while targeting $100M-$120M free cash flow amid China pricing uncertainty (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.26 - 01:46	QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
	QuidelOrtho (QDEL) delivered earnings and revenue surprises of -110.81% and +0.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...

06.05.26 - 01:00	QuidelOrtho (QDEL) Q1 2026 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.26 - 00:06	QuidelOrtho verfehlt Q1-Zahlen deutlich – Aktie bricht ein (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

05.05.26 - 22:08	QuidelOrtho Reports First Quarter 2026 Financial Results (PR Newswire)
	― LEX Diagnostics Acquisition Expected to Accelerate Growth in Point-of-Care Molecular Diagnostics ― ― Key Product Launches in U.S. and International Markets Expected to Drive Future Growth ― ― Company Updates Full-Year 2026 Financial Guidance ― SAN DIEGO, May 5, 2026 /PRNewswire/ --......

28.04.26 - 17:31	Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline (Zacks)
	QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

23.04.26 - 15:33	Understanding and Addressing Syphilis Trends - and What′s Being Missed (PR Newswire)
	SAN DIEGO, April 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 57 of its Science Bytes podcast, focusing on evolving syphilis trends in the United States and the rise of congenital syphilis cases despite......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Also denk bei allem, was dich in Kummer versetzt, daran, folgenden Leitsatz anzuwenden: Nicht nur ist das kein Unglück, sondern es tapfer zu tragen ist ein Glück. - Mark Aurel

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram